Infectious complications in neutropenic cancer patients

被引：10
作者：
Menichetti, Francesco [1 ]
机构：
[1] Nuovo Osped, Azienda Osped Univ Pisana, Pisa, Italy
来源：
INTERNAL AND EMERGENCY MEDICINE | 2010年 / 5卷
关键词：
Cancer; Neutropenia; Infectious complications; PREEMPTIVE ANTIFUNGAL THERAPY; HIGH-RISK; PROPHYLAXIS; FEVER;
D O I：
10.1007/s11739-010-0456-8
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Cancer patients are at risk of infectious complications due to neutropenia following chemotherapy or early post-HSCT (Hemato Stem Cell Transplantation). The first episode of fever during recent onset neutropenia is caused mostly by bacteria, while subsequent episodes are mainly fungal in nature. Proper management of infectious complications in neutropenic cancer patients requires classification into the appropriate risk category and knowledge of the local epidemiology of infections, of the causative organisms and their resistance phenotype.
引用
收藏
页码：S21 / S25
页数：5
相关论文
共 50 条
  • [31] Controversies in the management of fever in the neutropenic cancer patient
    Seftel, Matthew D.
    TRANSFUSION AND APHERESIS SCIENCE, 2010, 42 (02) : 151 - 156
  • [32] Infectious Risks and Complications in Adult Leukemic Patients Receiving Blinatumomab
    So, Wonhee
    Pandya, Shuchi
    Quilitz, Rod
    Shah, Bijal
    Greene, John N.
    MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES, 2018, 10
  • [33] Prognosis of acute respiratory distress syndrome in neutropenic cancer patients
    Mokart, Djamel
    van Craenenbroeck, Thomas
    Lambert, Jerome
    Textoris, Julien
    Brun, Jean-Paul
    Sannini, Antoine
    Chow-Chine, Laurent
    Hamouda, Smail
    Fouche, Louis
    Ettori, Florence
    Faucher, Marion
    Blache, Jean-Louis
    EUROPEAN RESPIRATORY JOURNAL, 2012, 40 (01) : 169 - 176
  • [34] How should imipenem-cilastatin be used in the treatment of fever and infection in neutropenic cancer patients?
    Raad, II
    Abi-Said, D
    Rolston, KV
    Karl, CL
    Bodey, GP
    CANCER, 1998, 82 (12) : 2449 - 2458
  • [35] Therapeutic management of febrile neutropenic patients in 1995
    Herbrecht, R
    Letscher, V
    MEDECINE ET MALADIES INFECTIEUSES, 1995, 25 : 27 - 35
  • [36] ITRACONAZOLE IN NEUTROPENIC PATIENTS
    VANTWOUT, JW
    CHEMOTHERAPY, 1992, 38 : 23 - 26
  • [37] Routine radiography does not have a role in the diagnostic evaluation of ambulatory adult febrile neutropenic cancer patients
    Nijhuis, CSMO
    Gietema, JA
    Vellenga, E
    Daenen, SMGJ
    De Bont, ESJM
    Kamps, WA
    Groen, HJM
    van der Jagt, EJ
    van der Graaf, WTA
    EUROPEAN JOURNAL OF CANCER, 2003, 39 (17) : 2495 - 2498
  • [38] THE EFFICACY OF TICARCILLIN-CLAVULANATE AND GENTAMICIN AS EMPIRIC TREATMENT FOR FEBRILE NEUTROPENIC PEDIATRIC-PATIENTS WITH CANCER
    YU, LC
    SHANEYFELT, T
    WARRIER, R
    ODE, D
    PEDIATRIC HEMATOLOGY AND ONCOLOGY, 1994, 11 (02) : 181 - 187
  • [39] Management of 315 neutropenic febrile episodes in a cancer center
    Dutronc, H.
    Billhot, M.
    Dupon, M.
    Eghbali, H.
    Donamaria, C.
    Dauchy, F. -A.
    Reiffers, J.
    MEDECINE ET MALADIES INFECTIEUSES, 2009, 39 (06): : 388 - 393
  • [40] Clinical features, aetiology and outcome of bacteraemic pneumonia in neutropenic cancer patients
    Gudiol, Carlota
    Royo-Cebrecos, Cristina
    Laporte, Julia
    Ardanuy, Carmen
    Garcia-Vidal, Carolina
    Antonio, Maite
    Arnan, Montserrat
    Carratala, Jordi
    RESPIROLOGY, 2016, 21 (08) : 1411 - 1418
12345